Chemoinformaics analysis of 1-(4-HYDROXYPHENYL)PENTAN-1-ONE
| Molecular Weight | 178.231 | nRot | 4 |
| Heavy Atom Molecular Weight | 164.119 | nRig | 2 |
| Exact Molecular Weight | 178.099 | nRing | 1 |
| Solubility: LogS | -3.782 | nHRing | 0 |
| Solubility: LogP | 4.091 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 29.3091 |
| nHD | 1 | BPOL | 14.9129 |
| QED | 0.356 |
| Synth | 2.906 |
| Natural Product Likeliness | 0.822 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.313 |
| MDCK | 0.000021 |
| BBB | 0.948 |
| PPB | 0.836221 |
| VDSS | 1.138 |
| FU | 0.230068 |
| CYP1A2-inh | 0.973 |
| CYP1A2-sub | 0.394 |
| CYP2c19-inh | 0.817 |
| CYP2c19-sub | 0.7 |
| CYP2c9-inh | 0.462 |
| CYP2c9-sub | 0.375 |
| CYP2d6-inh | 0.088 |
| CYP2d6-sub | 0.092 |
| CYP3a4-inh | 0.478 |
| CYP3a4-sub | 0.22 |
| CL | 10.004 |
| T12 | 0.292 |
| hERG | 0.014 |
| Ames | 0.008 |
| ROA | 0.036 |
| SkinSen | 0.486 |
| Carcinogencity | 0.052 |
| EI | 0.987 |
| Respiratory | 0.225 |
| NR-Aromatase | 0.013 |
| Antiviral | No |
| Prediction | 0.710331 |